GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraScience Inc (GREY:SCIE) » Definitions » COGS-to-Revenue

SpectraScience (SpectraScience) COGS-to-Revenue : 0.00 (As of Sep. 2017)


View and export this data going back to . Start your Free Trial

What is SpectraScience COGS-to-Revenue?

SpectraScience's Cost of Goods Sold for the three months ended in Sep. 2017 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2017 was $0.00 Mil.

SpectraScience's COGS to Revenue for the three months ended in Sep. 2017 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. SpectraScience's Gross Margin % for the three months ended in Sep. 2017 was N/A%.

SpectraScience COGS-to-Revenue Historical Data

The historical data trend for SpectraScience's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SpectraScience COGS-to-Revenue Chart

SpectraScience Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 0.52 - 0.14 39.80

SpectraScience Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 - - - -

SpectraScience COGS-to-Revenue Calculation

SpectraScience's COGS to Revenue for the fiscal year that ended in Dec. 2016 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.199 / 0.005
=39.80

SpectraScience's COGS to Revenue for the quarter that ended in Sep. 2017 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraScience  (GREY:SCIE) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

SpectraScience's Gross Margin % for the three months ended in Sep. 2017 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

SpectraScience COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of SpectraScience's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

SpectraScience (SpectraScience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraScience Inc (GREY:SCIE) » Definitions » COGS-to-Revenue
Comparable Companies
GTHP ESMC ACAR EQUR IGNG ACXA MDGS NSPR MRLB VYCO PHMD NUMD PBIOD PYNGF CHFS MPHMF AVGR MICR NIMU AHPI
Traded in Other Exchanges
N/A
Address
11568-11 Sorrento Valley Road, San Diego, CA, USA, 92121
Website
http://www.spectrascience.com
SpectraScience Inc is a US based company focused on developing the WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The firm has developed a technology platform to determine if the tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT operates by using cool, safe UV laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin treatment during the same procedure. The group sells its product in the United States and Europe, of which majority of the sales revenue is derived from the United States.
Executives
Lowell Giffhorn officer: CFO 10875 KEMAH LANE, SAN DIEGO CA 92131
John Pappajohn director 1660 WALT WHITMAN ROAD, SUITE 105, MELVILLE NY 11747
Euclidsr Partners, L.p. 10 percent owner 45 ROCKEFELLER PLAZA, SUITE 3240, NEW YORK NY 10111
Euclidsr Associates, L.p. 10 percent owner 45 ROCKEFELLER PLAZA, SUITE 3240, NEW YORK NY 10111
Tommy G Thompson director 7711 CARONDELET, ST. LOUIS MO 63105

SpectraScience (SpectraScience) Headlines

No Headlines